Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Cuttine edge: T cells from aged mice are resistant to depletion early during virus infection.

Jiang J, Anaraki F, Blank KJ, Murasko DM.

J Immunol. 2003 Oct 1;171(7):3353-7.

2.
3.
4.

Rational design of cytotoxic T-cell inhibitors.

Tretiakova AP, Little CS, Blank KJ, Jameson BA.

Nat Biotechnol. 2000 Sep;18(9):984-8.

PMID:
10973221
5.

Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice.

Panoutsakopoulou V, Hunter K, Sieck TG, Blankenhorn EP, Blank KJ.

J Virol. 1999 Nov;73(11):9232-6.

6.

Strain-dependent migration of lymphocytes to the vaginal mucosa after peripheral immunization.

Mulero-Marchese RD, Blank KJ, Sieck TG.

Immunogenetics. 1999 Oct;49(11-12):973-80.

PMID:
10501840
7.

Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

Mulero-Marchese RD, Blank KJ, Sieck TG.

J Infect Dis. 1998 Jul;178(1):227-34.

PMID:
9652445
8.
10.

Microsatellite typing of CXB recombinant inbred and parental mouse strains.

Panoutsakopoulou V, Spring P, Cort L, Sylvester JE, Blank KJ, Blankenhorn EP.

Mamm Genome. 1997 May;8(5):357-61. No abstract available.

PMID:
9107684
11.

Inhibition of T cell activation by an autoantibody induced by murine retrovirus infection.

Townsend RM, Dzuris JL, Mirza I, Sieck T, Coffman F, Blank KJ.

Clin Immunol Immunopathol. 1997 Mar;82(3):263-73.

PMID:
9073550
12.
13.

Environmental lighting alters the infection process in an animal model of AIDS.

McEachron DL, Tumas KM, Blank KJ, Prystowsky MB.

Pharmacol Biochem Behav. 1995 Aug;51(4):947-52.

PMID:
7675882
15.

A murine leukemia virus expressed in aged DBA/2 mice is derived by recombination of the Emv-3 locus and another endogenous gag sequence.

Bartman T, Murasko DM, Sieck TG, Turturro A, Hart R, Blank KJ.

Virology. 1994 Aug 15;203(1):1-7.

PMID:
8030264
16.

Differences between young and aged mice in susceptibility to Friend virus.

Stewart DR, Kirschmann DA, Blank KJ, Murasko DM.

Mech Ageing Dev. 1994 Feb;73(2):145-55.

PMID:
7519701
17.
18.

Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line.

Sieck TG, Moors MA, Buckley HR, Blank KJ.

Infect Immun. 1993 Aug;61(8):3540-3.

19.

Superantigens and microbial pathogenesis.

Taub DD, Blank KJ.

Ann Intern Med. 1993 Jul 1;119(1):89-90. No abstract available.

PMID:
8498771
20.
21.

Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.

Tumas KM, Poszgay JM, Avidan N, Ksiazek SJ, Overmoyer B, Blank KJ, Prystowsky MB.

Virology. 1993 Feb;192(2):587-95.

PMID:
7678475
22.

Murine leukemia virus infection in immunocompetent adult mice.

Tumas K, Overmoyer B, Clevenger CV, Blank KJ, Prystowsky MB.

Virology. 1993 Jan;192(1):1-10.

PMID:
8390745
24.

Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes.

Rosenthal LA, Taub DD, Moors MA, Blank KJ.

Immunopharmacology. 1992 Nov-Dec;24(3):203-17.

PMID:
1478854
26.

Direct involvement of the CDR3-like domain of CD4 in T helper cell activation.

McDonnell JM, Blank KJ, Rao PE, Jameson BA.

J Immunol. 1992 Sep 1;149(5):1626-30.

PMID:
1387146
27.

A role for complement receptor-like molecules in iron acquisition by Candida albicans.

Moors MA, Stull TL, Blank KJ, Buckley HR, Mosser DM.

J Exp Med. 1992 Jun 1;175(6):1643-51.

28.

Altered macrophage antigen-presenting cell function following Friend leukemia virus infection.

Jones SM, Moors MA, Ryan Q, Klyczek KK, Blank KJ.

Viral Immunol. 1992 Fall;5(3):201-11.

PMID:
1418318
29.

Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins.

Punt JA, Kubo RT, Saito T, Finkel TH, Kathiresan S, Blank KJ, Hashimoto Y.

J Exp Med. 1991 Oct 1;174(4):775-83.

30.

Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness.

Korostoff JM, Nakada MT, Faas SJ, Blank KJ, Gaulton GN.

J Exp Med. 1990 Dec 1;172(6):1765-75.

31.

Specific infection of central nervous system white matter by a variant of gross murine leukemia virus.

Simonian NA, Rosenthal LA, Korostoff J, Hickey WF, Blank KJ, Gaulton GN.

Virology. 1990 Jul;177(1):384-7.

PMID:
2353463
32.

Effect of Friend leukemia virus infection on susceptibility to Candida albicans.

Moors MA, Jones SM, Klyczek KK, Rogers TJ, Buckley HR, Blank KJ.

Infect Immun. 1990 Jun;58(6):1796-801.

33.

T cell receptor genes and T cell development in virus-transformed early T cell lines.

Hashimoto Y, Blank KJ.

J Immunol. 1990 Feb 15;144(4):1518-25.

PMID:
2303715
34.

In vivo generation of antigenic variants of murine retroviruses.

Pozsgay JM, Klyczek KK, Blank KJ.

Virology. 1989 Nov;173(1):330-4.

PMID:
2479171
35.

Signalling through sIgA on a novel murine B lymphoma.

Monroe JG, Blank KJ, Owen CS, Sykes N.

Mol Immunol. 1989 Jul;26(7):593-9.

PMID:
2550816
36.

Novel class I-like molecule expressed on a murine leukemia virus-transformed cell line.

Klyczek KK, Blank KJ.

Cell Immunol. 1989 Jan;118(1):222-8.

PMID:
2642746
37.

Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma.

McKernan LN, Blank KJ, Spitalny GL, Murasko DM.

Cell Immunol. 1988 Jul;114(2):432-9.

PMID:
2455606
38.

Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains.

Wegmann KW, Blank KJ, Green WR.

Cell Immunol. 1988 May;113(2):308-19.

PMID:
2834071
40.

Host genetic control of retrovirus-induced leukemogenesis in the mouse: direct genetic and epistatic effects.

Blank KJ, Klyczek KK.

J Leukoc Biol. 1986 Oct;40(4):479-90. Review. No abstract available.

PMID:
3018115
42.

Antigenic changes in gp70 associated with the adult variant of Gross murine leukemia virus, WB91.

Jones SM, Spear BT, Klyczek KK, Pozsgay JM, Gaudet E, Yao D, Blank KJ.

Microb Pathog. 1986 Jun;1(3):275-82.

PMID:
3508491
43.

Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation.

Blank KJ, McKernan LN, Murasko DM.

J Interferon Res. 1985 Winter;5(1):215-21.

PMID:
3872918
44.
45.
46.
47.

Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.

Wettstein PJ, Blank KJ.

J Immunol. 1982 Jul;129(1):358-61.

PMID:
7086137
48.

Inhibition of virus-induced murine diabetes by an interferon inducer.

Gadzik JP, Naji A, Barker CF, Blank KJ.

J Interferon Res. 1982;2(1):59-63. No abstract available.

PMID:
6286804
49.

Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines.

Wolfe JH, Blank KJ, Pincus T.

Immunogenetics. 1981;12(1-2):187-90. No abstract available.

PMID:
7203555
50.

Effect of anti-interferon serum on Friend virus infection and Fv-1-mediated resistance.

Blank KJ, Murasko DM.

J Interferon Res. 1981;1(3):437-42.

PMID:
6180076

Supplemental Content

Loading ...
Support Center